Physician profile
Vincent Sollecito
NPI 1649236357
$221,046.75
in general payments reported to CMS, 2019-2025
29 companies · $41K in 2025
The $41K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $21K · 2021: $18K · 2022: $30K · 2023: $40K · 2024: $52K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $94K · Travel and Lodging: $24K · Food and Beverage: $7,761 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $94,106.25 |
| Travel and Lodging | $24,082.40 |
| Food and Beverage | $7,760.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,380.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $153,833.78 | 2019-2025 | |
| Smith+Nephew, INC. | $51,852.96 | 2019-2025 | Versajet, Collagenase Santyl, Oasis Micro |
| Triad Life Sciences INC. | $11,021.19 | 2021-2022 | |
| Elite Orthopedics, LLC | $1,228.60 | 2021-2023 | |
| Stryker Corporation | $846.09 | 2019-2022 | |
| Organogenesis INC. | $587.61 | 2019-2023 | Puraply, Affinity |
| Kci USA, INC. | $387.79 | 2019-2023 | Prevena, V.A.C. Veraflo |
| Integra Lifesciences Corporation | $225.93 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ets Wound Care LLC | $178.92 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Nevro Corp. | $120.41 | 2022-2024 | Senza |
| Paratek Pharmaceuticals, INC. | $111.42 | 2021-2025 | Nuzyra |
| Reprise Biomedical, INC. | $89.84 | 2025 | Miro3d |
| Tactile Systems Technology INC | $72.54 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Solventum Corporation | $67.95 | 2024-2025 | Activ.A.C., Prevena, 3m Coban |
| Globus Medical, INC. | $62.51 | 2025 | Senza |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $42.31 | 2023-2024 | Qutenza |
| Tei Medical INC. | $40.12 | 2019 | |
| Linvatec Corporation | $33.84 | 2025 | Rts |
| Bioventus LLC | $33.67 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Acera Surgical, INC. | $33.28 | 2023-2025 | Restrata Wound Matrix |
| Medtronic, INC. | $28.11 | 2025 | Closurefast |
| Ethicon US, LLC | $27.57 | 2022 | |
| Sanara Medtech INC. | $22.13 | 2021 | |
| Avita Medical Americas, LLC | $18.56 | 2024 | |
| Hydrofera LLC | $17.93 | 2023 | Hydrofera Blue |
| Abbvie INC. | $17.50 | 2023 | Dalvance |
| Urgo Medical North America, LLC | $15.16 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Advanced Oxygen Therapy INC. | $15.08 | 2021 | |
| Biocomposites INC | $13.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Sollecito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.